Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn R Lockhart

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Fungal Genetics and Biology : FG & B|June 23, 2019
Candida auris and multidrug resistance: Defining the new normalShawn R Lockhart
Clinical Microbiology Newsletter|March 31, 2025
Current Epidemiology of <i>Candida</i> InfectionShawn R Lockhart
Journal of Clinical Microbiology|October 15, 2011
Do hospital microbiology laboratories still need to distinguish Candida albicans from Candida dubliniensis?Shawn R Lockhart
Seminars in Diagnostic Pathology|April 24, 2019
Emerging and reemerging fungal infectionsShawn R Lockhart, Jeannette Guarner
Current Fungal Infection Reports|November 10, 2017
An invisible threat: mutation-mediated resistance to triazole drugs in <i>Aspergillus</i>Cau D Pham, Shawn R Lockhart
Clinical Microbiology Newsletter|March 17, 2025
Antifungal Susceptibility Testing - The Times They Are a Changin'Shawn R Lockhart, Elizabeth L Berkow
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2015
Microbroth Dilution Susceptibility Testing of Candida speciesRandal J Kuykendall, Shawn R Lockhart
Current Fungal Infection Reports|November 4, 2015
Recent Taxonomic Developments with <i>Candida</i> and Other Opportunistic YeastsMary E Brandt, Shawn R Lockhart
The Journal of Antimicrobial Chemotherapy|August 8, 2018
Activity of novel antifungal compound APX001A against a large collection of Candida aurisElizabeth L Berkow, Shawn R Lockhart
Diagnostic Microbiology and Infectious Disease|January 9, 2018
Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida aurisElizabeth L Berkow, Shawn R Lockhart
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Fungal Genetics and Biology : FG & B|June 23, 2019
Candida auris and multidrug resistance: Defining the new normalShawn R Lockhart
Clinical Microbiology Newsletter|March 31, 2025
Current Epidemiology of <i>Candida</i> InfectionShawn R Lockhart
Journal of Clinical Microbiology|October 15, 2011
Do hospital microbiology laboratories still need to distinguish Candida albicans from Candida dubliniensis?Shawn R Lockhart
Seminars in Diagnostic Pathology|April 24, 2019
Emerging and reemerging fungal infectionsShawn R Lockhart, Jeannette Guarner
Current Fungal Infection Reports|November 10, 2017
An invisible threat: mutation-mediated resistance to triazole drugs in <i>Aspergillus</i>Cau D Pham, Shawn R Lockhart
Clinical Microbiology Newsletter|March 17, 2025
Antifungal Susceptibility Testing - The Times They Are a Changin'Shawn R Lockhart, Elizabeth L Berkow
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2015
Microbroth Dilution Susceptibility Testing of Candida speciesRandal J Kuykendall, Shawn R Lockhart
Current Fungal Infection Reports|November 4, 2015
Recent Taxonomic Developments with <i>Candida</i> and Other Opportunistic YeastsMary E Brandt, Shawn R Lockhart
The Journal of Antimicrobial Chemotherapy|August 8, 2018
Activity of novel antifungal compound APX001A against a large collection of Candida aurisElizabeth L Berkow, Shawn R Lockhart
Diagnostic Microbiology and Infectious Disease|January 9, 2018
Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida aurisElizabeth L Berkow, Shawn R Lockhart
Pageof 26